The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Standard anthracycline-based vs. docetaxel-capecitabine in early breast cancer: Results from the chemotherapy randomization (R-C) of EORTC 10041/ BIG 3-04 MINDACT phase III trial.
 
Fatima Cardoso
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Genentech; Macrogenics; Merck Sharp & Dohme; Merus; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Teva
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Martine J. Piccart-Gebhart
Consulting or Advisory Role - AstraZeneca; Crescendo Biologics; Debiopharm Group; HUYA Bioscience International; Lilly; MSD; Novartis; Periphagen; Pfizer; PharmaMar; Radius Health; Roche/Genentech
Research Funding - AstraZeneca (Inst); Crescendo Bioscience (Inst); Debiopharm Group (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Periphagen (Inst); Pfizer (Inst); PharmaMar (Inst); Radius Health (Inst); Roche/Genentech (Inst)
 
Emiel J. Rutgers
No Relationships to Disclose
 
Saskia Litière
Research Funding - Tesaro
 
Laura Van't Veer
Employment - Agendia
Leadership - Agendia
Stock and Other Ownership Interests - Agendia
 
Giuseppe Viale
Consulting or Advisory Role - AstraZeneca; Dako; Roche/Genentech
Travel, Accommodations, Expenses - Celgene; Roche
 
Jean-Yves Pierga
Consulting or Advisory Role - AstraZeneca; Ipsen; Janssen Diagnostics (Inst); Novartis; Roche/Genentech; SERVIER (Inst)
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca
 
Franchette W.P.J. van den Berkmortel
Consulting or Advisory Role - Janssen-Cilag
 
Etienne Brain
Honoraria - AstraZeneca; Hospira; Janssen; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Hospira; OBI Pharma; Roche
Research Funding - Amgen (Inst); HalioDx (Inst); Teva (Inst)
Travel, Accommodations, Expenses - Pfizer; Pfizer; Pierre Fabre; Roche
 
Patricia Gomez
No Relationships to Disclose
 
Theodora Goulioti
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - GlaxoSmithKline
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); SERVIER (Inst); Tesaro (Inst)
 
Susan Knox
Stock and Other Ownership Interests - Lilly
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Elisabeth Luporsi
No Relationships to Disclose
 
Ulrike Nitz
No Relationships to Disclose
 
Isabel T Rubio
No Relationships to Disclose
 
Lisette Stork
Employment - Agendia
Consulting or Advisory Role - Medex15
 
Peter Vuylsteke
No Relationships to Disclose
 
KONSTANTINOS TRYFONIDIS
Research Funding - Puma Biotechnology (Inst); Tesaro (Inst)
 
Jan Bogaerts
No Relationships to Disclose
 
Suzette Delaloge
No Relationships to Disclose